It has gained attention for its potential role in weight management , thanks to its bioactive compounds, including fiber , saponins , flavonoids , and alkaloids
However, HBOT has established and emerging applications in certain areas of supportive cancer care
aligns with phase 2 obesity trial readouts
March 8, 2026: More Deaths, Adverse Events Reported About Patients Taking Mounjaro, Other GLP-1s The U.K.s Medicines and Healthcare products Regulatory Authority received 1,296 reports of pancreatitis involving patients taking GLP-1 drugs (like Mounjaro) between 2007 and 2025
Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme a dehydrogenase deficiency caused by the G1528C mutation
This product is not intended as a medical treatment